Back to DM DME Capital Management, LP

NUVBNUVB

Showing 8 of 10 quarters

Position history for DMDME Capital Management, LP's holdings in NUVATION BIO INC

Yes. DME Capital Management holds 34,995 shares of NUVB (Nuvation Bio), worth $198,772, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. DME Capital Management has held NUVB in every 13F on record since Q1 2024, 10 quarterly filings.

Current Value

$198,772

Current Shares

34,995

Total Value Change

+$118,633

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
34,995
0.0%
$198,7720.0%$5.68
0
2026-Q1
Unchanged
34,995
0.0%
$150,1290.0%$4.29
0
2025-Q4
Unchanged
34,995
0.0%
$313,5550.0%$8.96
0
2025-Q3
Unchanged
34,995
0.0%
$129,4820.0%$3.70
0
2025-Q2
Unchanged
34,995
0.0%
$68,2400.0%$1.95
0
2025-Q1
Unchanged
34,995
0.0%
$61,5910.0%$1.76
0
2024-Q4
Unchanged
34,995
0.0%
$93,0870.0%$2.66
0
2024-Q3
Unchanged
34,995
0.0%
$80,1390.0%$2.29
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used